MILLENNIUM MANAGEMENT LLC - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 76 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2015$43,000
-82.4%
35,534
-67.7%
0.00%
Q3 2015$245,000
+202.5%
110,005
+217.7%
0.00%
Q2 2015$81,000
+62.0%
34,629
+60.2%
0.00%
Q4 2014$50,000
-46.2%
21,622
-37.7%
0.00%
Q3 2014$93,000
-96.2%
34,717
-94.8%
0.00%
-100.0%
Q2 2014$2,477,000
-44.4%
663,947
+75.2%
0.01%
-46.2%
Q1 2014$4,457,000
+3016.8%
379,033
+2105.0%
0.01%
Q4 2013$143,00017,1900.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q1 2014
NameSharesValueWeighting ↓
Virtu KCG Holdings LLC 86,824$31,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$17,0000.00%
DEUTSCHE BANK AG\ 1,405$00.00%
CITIGROUP INC 9,751$4,0000.00%
GOLDMAN SACHS GROUP INC 17,281$6,0000.00%
MORGAN STANLEY 4,250$2,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 48,944$18,0000.00%
BlackRock Inc. 927,688$334,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 6,600$2,0000.00%
Bank of New York Mellon Corp 62,846$22,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders